SI-BONE
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, SI-BONE sits in the top decile of US sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count).
SI-BONE: 10 sponsored US clinical trials, none currently recruiting.
SI-BONE sponsors 10 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Sacroiliac Dysfunction, with 1 trials.
Top-decile sponsor footprint
SI-BONE ranks in the top decile of sponsors by registered trial count (#1,331 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
10 total, page 1 of 1
Innovative Spinopelvic Solutions With Real-World Evidence
NCT06706908
Pelvic Fixation and Fusion During Multilevel Spinal Surgery
NCT05640908
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
NCT05870488
Sacral Fracture Fusion/Fixation for Rapid Rehabilitation
NCT05426356
SI Joint Stabilization in Long Fusion to the Pelvis
NCT04062630
Study of Bone Growth in the Sacroiliac Joint After Minimally Invasive Surgery With Titanium Implants
NCT03122899
LOIS: Long-Term Follow-Up in INSITE/SIFI
NCT02270203
Validity and Reliability of Diagnostic Findings of SI Joint Blocking
NCT01874236
Investigation of Sacroiliac Fusion Treatment (INSITE)
NCT01681004
Sacroiliac Joint Fusion With iFuse Implant System (SIFI)
NCT01640353
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 2 |
Therapeutic Areas
How the SI-BONE archive is shaped
10 indexed studies, none listed as recruiting (0% open); 5 completed (50%).
Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Sacroiliac Dysfunction (1 trial), 6 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
SI-BONE: archived-pipeline peers nationwide
Peers matched on 10 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
SI-BONE sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 10 archived trials
- Adamas Pharmaceuticals · 10 trials · 0% recruiting
- Adverum Biotechnologies · 10 trials · 30% recruiting
- Aevi Genomic Medicine, LLC, a Cerecor company · 10 trials · 0% recruiting
- Agouron Pharmaceuticals · 10 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this SI-BONE page
10 registered trials is a research-attention snapshot, not an endorsement of SI-BONE or any single study.
- None of SI-BONE's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Sacroiliac Dysfunction is the condition SI-BONE studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Sacroiliac Dysfunction trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. SI-BONE pipeline card: 10 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.